What does this procedure involve?

This combined treatment for diabetic retinopathy or retinal vein occlusion consists of three monthly intravitreal injections of conbercept, an anti-VEGF medication that reduces abnormal blood vessel growth and leakage. Following each injection, scatter (panretinal) laser photocoagulation is applied to the peripheral retina to seal leaking vessels and prevent further damage. The entire course spans three months and is performed as an outpatient procedure under local anesthesia.